BBIO
BridgeBio Pharma, Inc.Company with tickers: BBIO
CIK
1743881
CUSIP
10806X102
Shares Outstanding
195,861,242
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $116,633,000 | USD | 2025-03-31 | 10-Q | 2026-05-07 |
| Cost of Revenue | $2,639,000 | USD | 2025-03-31 | 10-Q | 2026-05-07 |
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $111,431,000 | USD | 2025-03-31 | 10-Q | 2026-05-07 |
| Operating Income | $-104,372,000 | USD | 2025-03-31 | 10-Q | 2026-05-07 |
| Net Income | — | ||||
| EPS (Basic) | $-0.88 | USD/shares | 2025-03-31 | 10-Q | 2026-05-07 |
| EPS (Diluted) | $-0.88 | USD/shares | 2025-03-31 | 10-Q | 2026-05-07 |